New Insights Into the Anti-Diabetic Actions of Metformin: From the Liver to the Gut

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023 · see citing works

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419 · see citing works

Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action

Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · see citing works

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · see citing works

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116 · see citing works

The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin

Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · see citing works

An increase in the <i>Akkermansia</i> spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550 · see citing works

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I

El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399 · see citing works

Clinical pharmacokinetics of metformin

Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318 · see citing works

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284 · see citing works

Metformin Inhibits Hepatic Gluconeogenesis in Mice Independently of the LKB1/AMPK Pathway via a Decrease in Hepatic Energy State

Foretz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181 · see citing works

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148 · see citing works

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

Shu, Y., Sheardown, S. A., Brown, C., Owen, R., Zhang, S., Castro, R. A., Ianculescu, A. G., Lin, Y., Lo, J. C.-M., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 963 · see citing works

Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats

Islam, K. B. M. S., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., Ogura, Y., Hayashi, T., & Yokota, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.046 · Cited by 918 · see citing works

Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin

Fullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893 · see citing works

Farnesoid X receptor is essential for normal glucose homeostasis

Ma, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25604 · Cited by 883 · see citing works

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

Miller, R., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 828 · see citing works

Glucose Sensing in L Cells: A Primary Cell Study

Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · cited 1× · see citing works

Intestinal Integrity and <i>Akkermansia muciniphila</i> , a Mucin-Degrading Member of the Intestinal Microbiota Present in Infants, Adults, and the Elderly

Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M., & Salminen, S. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01477-07 · Cited by 706 · see citing works

Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man

EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654 · see citing works

Metformin in Patients With Type 2 Diabetes and Kidney Disease: A Systematic Review

Inzucchi, S. E., Lipska, K. J., Mayo, H., Bailey, C. J., & McGuire, D. K. (2014) · JAMA · doi:10.1001/jama.2014.15298 · Cited by 601 · see citing works

Metformin kinetics in healthy subjects and in patients with diabetes mellitus.

Tucker, G., Casey, C., Phillips, P., Connor, H., Ward, J. D., & Woods, H. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01206.x · Cited by 497 · see citing works

Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein

He, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M. A., Radovick, S., & Wondisford, F. E. (2009) · Cell · doi:10.1016/j.cell.2009.03.016 · Cited by 479 · see citing works

Metformin Action: Concentrations Matter

He, L., & Wondisford, F. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.003 · Cited by 448 · see citing works

Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse

Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418 · see citing works

Metformin Activates a Duodenal Ampk-Dependent Pathway to Lower Hepatic Glucose Production in Rats

Duca, F. A., Côté, C. D., Rasmussen, B. A., Zadeh-Tahmasebi, M., Rutter, G. A., Filippi, B. M., & Lam, T. K. T. (2015) · Nature Medicine · doi:10.1038/nm.3787 · Cited by 402 · see citing works

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

Pournaras, D. J., Glicksman, C., Vincent, R. P., Kuganolipava, S., Alaghband-Zadeh, J., Mahon, D., Bekker, J. H. R., Ghatei, M. A., Bloom, S. R., Walters, J. R. F., et al. (2012) · Endocrinology · doi:10.1210/en.2011-2145 · Cited by 383 · see citing works

The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-Term Pharmacokinetic and 12-Week Dose-Ranging Studies

Buse, J. B., DeFronzo, R. A., Rosenstock, J., Kim, T., Burns, C., Skare, S., Baron, A., & Fineman, M. (2016) · Diabetes Care · doi:10.2337/dc15-0488 · Cited by 325 · see citing works

Cardiovascular Outcomes in Trials of Oral Diabetes Medications: A Systematic Review

Selvin, E., Bolen, S., Yeh, H.-C., Wiley, C., Wilson, L. M., Marinopoulos, S. S., Feldman, L., Vassy, J., Wilson, R., Bass, E. B., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.19.2070 · Cited by 300 · see citing works

Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice

Maida, A., Lamont, B. J., Cao, X., & Drucker, D. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1937-z · Cited by 293 · see citing works

Metformin activates AMPK through the lysosomal pathway

Zhang, C.-S., Li, M., Ma, T., Zong, Y., Cui, J., Feng, J.-W., Wu, Y.-Q., Lin, S.-Y., & Lin, S.-C. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.003 · Cited by 280 · see citing works

Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention

Gottwald‐Hostalek, U., Gwilt, M., & Hildemann, S. K. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278 · see citing works

Metformin and the Intestine

Bailey, C. J., Wilcock, C., & Scarpello, J. H. B. (2008) · Diabetologia · doi:10.1007/s00125-008-1053-5 · Cited by 275 · see citing works

Gastric emptying and glycaemia in health and diabetes mellitus

Phillips, L. K., Deane, A. M., Jones, K. L., Rayner, C. K., & Horowitz, M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.202 · Cited by 273 · see citing works

Metformin Rapidly Increases Insulin Receptor Activation in Human Liver and Signals Preferentially through Insulin-Receptor Substrate-2

Gunton, J. E., Delhanty, P. J. D., Takahashi, S., & Baxter, R. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021394 · Cited by 231 · see citing works

Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5

Caton, P., Nayuni, N. K., Kieswich, J. E., Khan, N. Q., Yaqoob, M. M., & Corder, R. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0345 · Cited by 197 · see citing works

High and typical 18F-FDG bowel uptake in patients treated with metformin

Gontier, E., Fourme, E., Wartski, M., Blondet, C., Bonardel, G., Stanc, E. L., Mantzarides, M., Foehrenbach, H., Pecking, A.-P., & Alberini, J. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0563-6 · Cited by 196 · see citing works

Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study

Zhou, K., Donnelly, L. A., Kimber, C. H., Donnan, P. T., Doney, A. S. F., Leese, G., Hattersley, A. T., McCarthy, M. I., Morris, A. D., Palmer, C. N. A., et al. (2009) · Diabetes · doi:10.2337/db08-0896 · Cited by 187 · see citing works

Vascular Effects of Improving Metabolic Control With Metformin or Rosiglitazone in Type 2 Diabetes

Natali, A., Baldeweg, S. E., Toschi, E., Capaldo, B., Barbaro, D., Gastaldelli, A., Yudkin, J. S., & Ferrannini, E. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1349 · Cited by 180 · see citing works

Secondary Failure of Metformin Monotherapy in Clinical Practice

Brown, J. B., Conner, C., & Nichols, G. A. (2009) · Diabetes Care · doi:10.2337/dc09-1749 · Cited by 178 · see citing works

Are Metformin Doses Used in Murine Cancer Models Clinically Relevant

Chandel, N. S., Avizonis, D., Reczek, C. R., Weinberg, S. E., Menz, S., Neuhaus, R., Christian, S., Haegebarth, A., Algire, C., & Pollak, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.010 · Cited by 176 · see citing works

Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)*

Cao, J., Meng, S., Chang, E., Beckwith-Fickas, K., Xiong, L., Cole, R. N., Radovick, S., Wondisford, F. E., & He, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567271 · Cited by 169 · see citing works

Bile acids and signal transduction: Role in glucose homeostasis

Nguyen, A., & Bouscarel, B. E. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.06.014 · Cited by 165 · see citing works

Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L Cell

Mulherin, A. J., Oh, A., Kim, H., Grieco, A. J., Lauffer, L. M., & Brubaker, P. L. (2011) · Endocrinology · doi:10.1210/en.2011-1485 · Cited by 158 · see citing works

Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers

Adrian, T. E., Gariballa, S., Parekh, K. A., Thomas, S. A., Saâdi, H., Alkaabi, J., Nagelkerke, N. J. D., Gedulin, B. R., & Young, A. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2593-2 · Cited by 143 · see citing works

Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes

Xu, T., Brandmaier, S., Messias, A. C., Herder, C., Draisma, H. H. M., Demirkan, A., Yu, Z., Ried, J. S., Haller, T., Heier, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0658 · Cited by 137 · see citing works

Pharmacokinetic-Pharmacodynamic Analysis of the Glucose-Lowering Effect of Metformin in Diabetic Rats Reveals First-Pass Pharmacodynamic Effect

Stepensky, D., Friedman, M., Raz, I., & Hoffman, A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.861 · Cited by 135 · see citing works

Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

DeFronzo, R. A., Buse, J. B., Kim, T., Burns, C. M., Skare, S., Baron, A., & Fineman, M. S. (2016) · Diabetologia · doi:10.1007/s00125-016-3992-6 · Cited by 131 · see citing works

Effect of metformin on glucose metabolism in the splanchnic bed

Bailey, C. J., Wilcock, C., & Day, C. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09093.x · Cited by 130 · see citing works

Effects of rectal administration of taurocholic acid on glucagon‐like peptide‐1 and peptide YY secretion in healthy humans

Wu, T., Bound, M. J., Standfield, S., Gedulin, B. R., Jones, K. L., Horowitz, M., & Rayner, C. K. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12043 · Cited by 124 · see citing works

Gut motility and enteroendocrine secretion

Wu, T., Rayner, C. K., Young, R. L., & Horowitz, M. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.002 · Cited by 110 · see citing works

Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia

Gu, W., Yan, H., Winters, K. A., Komorowski, R., Vonderfecht, S. L., Atangan, L. I., Sivits, G. N., Hill, D., Yang, J., Bi, V., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157685 · Cited by 105 · see citing works

The Effect of Intravenous Metformin on Glucose Metabolism During Hyperglycaemia in Type 2 Diabetes

Sum, C. ‐., Webster, J. M., Johnson, A. B., Catalano, C., Cooper, B. G., & Taylor, R. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01716.x · Cited by 103 · see citing works

Gut microbiota in health and disease: an overview focused on metabolic inflammation

Nagpal, R., Kumar, M., Yadav, A. K., Hemalatha, R., Yadav, H., Marotta, F., & Yamashiro, Y. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0062 · Cited by 97 · see citing works

Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine

Ikeda, T., Iwata, K., & Murakami, H. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00396-2 · Cited by 94 · see citing works

Type 2 diabetes alters metabolic and transcriptional signatures of glucose and amino acid metabolism during exercise and recovery

Hansen, J. S., Zhao, X., Irmler, M., Liu, X., Hoene, M., Scheler, M., Li, Y., Beckers, J., de Angelis, M. H., Häring, H., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3584-x · Cited by 90 · see citing works

Effects of Taurocholic Acid on Glycemic, Glucagon-like Peptide-1, and Insulin Responses to Small Intestinal Glucose Infusion in Healthy Humans

Wu, T., Bound, M. J., Standfield, S., Jones, K. L., Horowitz, M., & Rayner, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3961 · Cited by 84 · see citing works

Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus

Bytzer, P. M., Talley, N. J., Jones, M., & Horowitz, M. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00896.x · Cited by 83 · see citing works

Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion

Ferrannini, E., Camastra, S., Astiarraga, B., Nannipieri, M., Castro‐Perez, J. M., Xie, D., Wang, L., Chakravarthy, M. V., & Haeusler, R. A. (2015) · Diabetes · doi:10.2337/db15-0214 · Cited by 80 · see citing works

Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes

Wu, T., Xie, C., Wu, H., Jones, K. L., Horowitz, M., & Rayner, C. K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12812 · Cited by 75 · see citing works

Metformin-induced regulation of the intestinal D-glucose transporters.

Sakar, Y., Meddah, B., Faouzi, M. A., Cherrah, Y., Bado, A., & Ducroc, R. A. (2010) · PubMed · Cited by 72 · see citing works

Involvement of glucagon‐like peptide‐1 in the glucose‐lowering effect of metformin

Bahne, E., Hansen, M., Brønden, A., Sonne, D. P., Vilsbøll, T., & Knop, F. K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12697 · Cited by 72 · see citing works

Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: Stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?

Wu, T., Thazhath, S. S., Bound, M. J., Jones, K. L., Horowitz, M., & Rayner, C. K. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.004 · Cited by 70 · see citing works

A bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells

Pham, H., Hui, H., Morvaridi, S., Cai, J., Zhang, S., Tan, J., Wu, V., Levin, N., Knudsen, B. S., Goddard, W. A., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.149 · Cited by 70 · see citing works

Über Biguanide, II.: Die blutzucker‐senkende Wirkung der Biguanide

Slotta, K. H., & Tschesche, R. (1929) · Berichte der deutschen chemischen Gesellschaft (A and B Series) · doi:10.1002/cber.19290620605 · Cited by 68 · see citing works

Metformin and resveratrol ameliorate muscle insulin resistance through preventing lipolysis and inflammation in hypoxic adipose tissue

Zhao, W., Li, A., Feng, X., Hou, T., Liu, K., Liu, B., & Zhang, N. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.06.018 · Cited by 68 · see citing works

Sites of metformin-stimulated glucose metabolism

Wilcock, C., & Bailey, C. J. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90136-9 · Cited by 67 · see citing works

Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling

Kim, M.-H., Jee, J.-H., Park, S., Lee, M., Kim, K., & Lee, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0381 · Cited by 66 · see citing works

Overview of metformin: special focus on metformin extended release

Ali, S., & Fonseca, V. A. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.705829 · Cited by 66 · see citing works

Reconsideration of inhibitory effect of metformin on intestinal glucose absorption

Wilcock, C., & Bailey, C. J. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb06645.x · Cited by 61 · see citing works

Specific inhibition of bile acid transport alters plasma lipids and GLP-1

Rudling, M. J., Camilleri, M., Graffner, H., Holst, J. J., & Rikner, L. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0070-9 · Cited by 60 · see citing works

Incretins

Wu, T., Rayner, C. K., & Horowitz, M. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_9 · Cited by 60 · see citing works

Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients

Sonne, D. P., Hare, K. J., Martens, P. C., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00435.2012 · Cited by 59 · see citing works

Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in Type 2 diabetes mellitus

Koga, M., Otsuki, M., Kubo, M., Hashimoto, J., & Kasayama, S. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199808)15:8 · Cited by 58 · see citing works

Metformin effects revisited

Andújar-Plata, P., Pi-Sunyer, X., & Laferrère, B. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.022 · Cited by 58 · see citing works

Addition of metformin to exogenous glucagon-like peptide–1 results in increased serum glucagon-like peptide–1 concentrations and greater glucose lowering in type 2 diabetes mellitus

Cuthbertson, J., Patterson, S., O'Harte, F. P. M., & Bell, P. M. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.001 · Cited by 54 · see citing works

Effects of Sitagliptin on Glycemia, Incretin Hormones, and Antropyloroduodenal Motility in Response to Intraduodenal Glucose Infusion in Healthy Lean and Obese Humans and Patients With Type 2 Diabetes Treated With or Without Metformin

Wu, T., Ma, J., Bound, M. J., Checklin, H. L., Deacon, C. F., Jones, K. L., Horowitz, M., & Rayner, C. K. (2014) · Diabetes · doi:10.2337/db13-1627 · Cited by 52 · see citing works

Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects

Luna, V., Casauban, L., Sajan, M. P., Gomez-Daspet, J., Powe, J. L., Miura, A., Rivas, J., Standaert, M. L., & Farese, R. V. (2006) · Diabetologia · doi:10.1007/s00125-005-0112-4 · Cited by 50 · see citing works

Effects of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats

Lenzen, S., Lortz, S., & Tiedge, M. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02243-0 · Cited by 48 · see citing works

Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: Effects of pioglitazone and metformin treatment

Ciaraldi, T. P., Aroda, V. R., Mudaliar, S. R. D., & Henry, R. R. (2013) · Metabolism · doi:10.1016/j.metabol.2013.07.004 · Cited by 45 · see citing works

Increased skeletal muscle glucose uptake by rosemary extract through AMPK activation

Naimi, M., Tsakiridis, T. K., Stamatatos, T. C., Alexandropoulos, D. I., & Tsiani, E. (2014) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2014-0430 · Cited by 40 · see citing works

Inhibition of the multidrug and toxin extrusion ( MATE ) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans

Oh, J., Chung, H., Park, S., Yi, S., Jang, K., Kim, A., Yoon, J., Cho, J., Yoon, S. H., Jang, I., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12577 · Cited by 38 · see citing works

The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers

Morrissey, K. M., STOCKER, S. L., Chen, E. C., Castro, R. A., Brett, C. M., & Giacomini, K. M. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0332-9 · Cited by 31 · see citing works

Inhibition of bile salt absorption by blood-sugar lowering biguanides

Caspary, W. F., & Creutzfeldt, W. (1975) · Diabetologia · doi:10.1007/bf00429833 · Cited by 28 · see citing works

A role for endogenous peptide YY in tachykinin NK2 receptor‐triggered 5‐HT release from guinea pig isolated colonic mucosa

Kojima, S., Tohei, A., & Anzai, N. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02094.x · Cited by 17 · see citing works

Comparative Effects of Bile Diversion and Duodenal-Jejunal Bypass on Glucose and Lipid Metabolism in Male Diabetic Rats

Zhang, X., Liu, T., Wang, Y., Zhong, M., Zhang, G., Liu, S., Wu, T., Rayner, C. K., & Hu, S. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1925-y · Cited by 14 · see citing works

Biguanides and Gastric Emptying in Man

Eisner, M., & Berger, W. (2009) · Digestion · doi:10.1159/000197133 · Cited by 6 · see citing works

Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686 · see citing works

Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds

Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498 · see citing works

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan

Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278 · see citing works

Metformin: Is it a drug for all reasons and diseases?

Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R. S., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 282 · see citing works

The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases

Pascale, A., Marchesi, N., Govoni, S. M., Coppola, A., & Gazzaruso, C. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.03.011 · Cited by 240 · see citing works

The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus

Lee, C. B., Chae, S. U., Jo, S. J., Jerng, U. M., & Bae, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073566 · Cited by 149 · see citing works

Metformin and Aging: A Review

Glossmann, H. H., & Lutz, O. M. D. (2019) · Gerontology · doi:10.1159/000502257 · Cited by 149 · see citing works

Metformin

Rodriguez, J., Hiel, S., & Delzenne, N. M. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000468 · Cited by 113 · see citing works

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials

Nabrdalik, K., Skonieczna‐Żydecka, K., Irlik, K., Hendel, M., Kwiendacz, H., Łoniewski, I., Januszkiewicz, K., Gumprecht, J., & Lip, G. Y. H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.975912 · Cited by 110 · see citing works

Pleiotropic Effects of Metformin on Cancer

Schulten, H.-J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102850 · Cited by 86 · see citing works

Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids

Sansome, D. J., Xie, C., Veedfald, S., Horowitz, M., Rayner, C. K., & Wu, T. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13869 · Cited by 84 · see citing works

Metformin acts in the gut and induces gut-liver crosstalk

Tobar, N., Rocha, G. Z., Santos, A., Guadagnini, D., Assalin, H. B., de Camargo, J. A., Gonçalves, A. E. S. S., Pallis, F. R., Oliveira, A. G., Rocco, S. A., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211933120 · Cited by 78 · see citing works

Pharmacogenomic Studies of Current Antidiabetic Agents and Potential New Drug Targets for Precision Medicine of Diabetes

Zeng, Z., Huang, S., & Sun, T. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00922-x · Cited by 71 · see citing works

Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes

Silamiķele, L., Silamiķelis, I., Ustinova, M., Kalniņa, Z., Elbere, I., Petrovska, R., Kalniņa, I., & Kloviņš, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626359 · Cited by 60 · see citing works

Pharmacology of metformin – An update

Glossmann, H. H., & Lutz, O. M. D. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172782 · Cited by 61 · see citing works

Metformin: review of epidemiology and mechanisms of action in pancreatic cancer

Eibl, G., & Rozengurt, E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09977-z · Cited by 48 · see citing works

Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon‐like peptide‐1, and gastric emptying after oral glucose, in type 2 diabetes

Borg, M. J., Bound, M. J., Grivell, J., Sun, Z., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13567 · Cited by 49 · see citing works

Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors

Dąbrowski, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041680 · Cited by 47 · see citing works

A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes

Damanhouri, Z. A., Alkreathy, H. M., Alharbi, F. A., Abualhamail, H., & Ahmad, M. S. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.77206 · Cited by 48 · see citing works

Metformin: Metabolic Rewiring Faces Tumor Heterogeneity

Cioce, M., Pulito, C., Strano, S., Blandino, G., & Fazio, V. M. (2020) · Cells · doi:10.3390/cells9112439 · Cited by 41 · see citing works

Type 2 Diabetes and the Microbiome

Barlow, G. M., & Mathur, R. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac184 · Cited by 35 · see citing works

The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction

Xiao, F., Gao, F., Zhou, S., & Wang, L. (2020) · Medicine · doi:10.1097/md.0000000000022249 · Cited by 32 · see citing works

An update on mode of action of metformin in modulation of meta-inflammation and inflammaging

Khodadadi, M., Jafari-Gharabaghlou, D., & Zarghami, N. (2022) · Pharmacological Reports · doi:10.1007/s43440-021-00334-z · Cited by 32 · see citing works

The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin

Kopel, J. J., Higuchi, K., Ristić, B., Sato, T., Ramachandran, S., & Ganapathy, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-65621-w · Cited by 29 · see citing works

An investigation into the pleiotropic activity of metformin. A glimpse of haemostasis

Markowicz-Piasecka, M., Sadkowska, A., Huttunen, K. M., Podsiedlik, M., Mikiciuk‐Olasik, E., & Sikora, J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172984 · Cited by 29 · see citing works

Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes

Anwardeen, N. R., Naja, K., & Elrayess, M. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1506767 · Cited by 27 · see citing works

Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis

Szymczak-Pajor, I., Drzewoski, J., Wenclewska, S., & Śliwińska, A. (2024) · Pharmaceuticals · doi:10.3390/ph17070898 · Cited by 24 · see citing works

A Single Dose of Oral Metformin Reduces the Post-Prandial Glucose Response Through a Transient Modulation of Apical Sodium-Glucose Co-Transporter

Zubiaga, L., Briand, O., Auger, F., Touche, V., Hübert, T., Thévenet, J., Marciniak, C., Quenon, A., Bonner, C., Peschard, S., et al. (2019) · iScience · doi:10.1016/j.isci.2023.106057 · Cited by 23 · see citing works

Pharmacological management of type 2 diabetes: what’s new in 2017?

Scheen, A. J. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1376652 · Cited by 23 · see citing works

Diabetes and skin cancers: Risk factors, molecular mechanisms and impact on prognosis

Dobrică, E.-C., Banciu, L. M., Kipkorir, V., Tabari, M. A. K., Cox, M. J., Kutikuppala, L. V. S., & Găman, M. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i31.11214 · Cited by 23 · see citing works

Regulating the absorption and excretion of perfluorooctane sulfonate and its alternatives through influencing enterohepatic circulation

Wen, Y., Juhasz, A. L., & Cui, X. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.173161 · Cited by 19 · see citing works

Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study

Xie, C., Iroga, P. E., Bound, M. J., Grivell, J., Huang, W., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2024) · Diabetologia · doi:10.1007/s00125-024-06131-6 · Cited by 21 · see citing works

Is metformin a geroprotector? A peek into the current clinical and experimental data

Zajda, A., Huttunen, K. M., Sikora, J., Podsiedlik, M., & Markowicz-Piasecka, M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111350 · Cited by 16 · see citing works

Skeletal muscle adaptations to exercise are not influenced by metformin treatment in humans: secondary analyses of 2 randomized, clinical trials

Pilmark, N. S., Oberholzer, L., Halling, J. F., Kristensen, J. M., Petersen-Bønding, C., Elkjær, I., Lyngbæk, M. P. P., Legaard, G. E., Siebenmann, C., Holm, N. F. R., et al. (2021) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2021-0194 · Cited by 13 · see citing works

Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin

Borg, M. J., Rayner, C. K., Jones, K. L., Horowitz, M., Xie, C., & Wu, T. (2020) · Pharmaceuticals · doi:10.3390/ph13110410 · Cited by 15 · see citing works

Extraction, phytochemicals characterization, in vivo and in vitro anti-diabetic ability of non-extractable polyphenols from Undaria pinnatifida

Peng, C., Xie, Q.-Y., Xie, X., Tang, L.-Y., Ma, T.-X., Ke, D.-W., Tu, Z.-C., & Zhang, L. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115021 · Cited by 11 · see citing works

The stress polarity pathway: AMPK 'GIV'-es protection against metabolic insults

Ghosh, P. (2017) · Aging · doi:10.18632/aging.101179 · Cited by 10 · see citing works

Low-dose metformin requires brain Rap1 for its antidiabetic action

Lin, H., Lu, W., He, Y., Fu, Y., Kaneko, K., Huang, P., la Puente-Gomez, A. B. D., Wang, C., Yang, Y., Li, F., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu3700 · Cited by 10 · see citing works

Region-Specific Effects of Metformin on Gut Microbiome and Metabolome in High-Fat Diet-Induced Type 2 Diabetes Mouse Model

Cheng, M., Jia, X., Ren, L., Chen, S., Wang, W., Wang, J., & Cong, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137250 · Cited by 8 · see citing works

A novel berberine‐metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats

Jia, D. T., Li, Z. W., Zhou, X., Gao, Y., Feng, Y., Ma, M., Wu, Z., & Li, W. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13085 · Cited by 8 · see citing works

The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance

Banerjee, Y., Patti, A. M., Giglio, R. V., Ciaccio, M., Vichithran, S., Faisal, S., Stoian, A. P., Rizvi, A. A., & Rizzo, M. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108517 · Cited by 8 · see citing works

Impact of gastric emptying and small intestinal carbohydrate absorption on glycemia in health and diabetes: therapeutic implications

Jalleh, R. J., Wu, T., Umapathysivam, M. M., Young, R. L., Jones, K. L., Marathe, C. S., Rayner, C. K., Plummer, M. P., & Horowitz, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00009.2025 · Cited by 6 · see citing works

Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administration

Borg, M. J., Xie, C. H., Chen, C., Bound, M. J., Grivell, J., Huang, W., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16570 · Cited by 5 · see citing works

Metformin Use Beyond Diabetes: Reducing Cardiovascular Events In The Healthy Elderly

Xu, D. (2020) · Gerontology & Geriatric Medicine · doi:10.24966/ggm-8662/100058 · Cited by 4 · see citing works

Selenium‐Enriched Submerged Fermentation of Tricholoma matsutake and Antioxidant and Hypoglycemic Activities of Its Mycelial Polysaccharide

Liu, J., Wang, Y., Zhong, Z., Yu, M., Zhou, X., Luo, H., Xiang, Y., Xu, M., Yi, Z., Zhu, X., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.71224 · Cited by 4 · see citing works

Effects of Gossypetin on Glucose Homeostasis in Diet-Induced Pre-Diabetic Rats

Naidoo, K., & Khathi, A. (2024) · Molecules · doi:10.3390/molecules29184410 · Cited by 4 · see citing works

Non‐Linear Dose–Response Relationship for Metformin in Japanese Patients With Type 2 Diabetes: Analysis of Irregular Longitudinal Data by Interpretable Machine Learning Models

Akimoto, H., Nagashima, T., Minagawa, K., Hayakawa, T., Takahashi, Y., & Asai, S. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70055 · Cited by 3 · see citing works

Metformin in the Era of New Antidiabetics

Al-Mahdi, E. A. R., Barrios, V., & Zamorano, J. L. (2021) · Future Cardiology · doi:10.2217/fca-2020-0195 · Cited by 2 · see citing works

Infused Oyster Mushroom (Pleurotus ostreatus) Inhibits Glucose Absorption through Intestinal Mucosal Membrane in Wistar Rats

Ariyanto, E. F., Shahib, M. N., & Wargahadibrata, A. F. (2018) · International Journal of Integrated Health Sciences · doi:10.15850/1354 · Cited by 1 · see citing works

A Comparative Study of Analytical Methods for Empagliflozin and Related Drugs

Kajol, Rana, A. S., Kaushik, A., Sharma, N., & Ashawat, M. S. (2025) · Glucolipid metabolic disorders · doi:10.2174/0129499011332816250311185959 · Cited by 1 · see citing works

Systematic Survey of Creatinine-Based Versus Cystatin C-based Estimated GFR in People with Diabetes

Acaralp, S., & Akhondi, H. A. (2020) · HCA Healthcare Journal of Medicine · doi:10.36518/2689-0216.1034

Managing metabolic syndrome in patients with schizophrenia

Singh, F., & Allen, A. (2020) · Current Psychiatry · doi:10.12788/cp.0064

Ethological and Physiological Harmful Effects of Metformin, An Antidiabetic Used to Treat Type 2-Diabetes: A Study on Ants as Biological Models

Cammaerts, M.-C., & Cammaerts, D. (2022) · International Journal of Biology · doi:10.5539/ijb.v14n2p27

Ethological and Physiological Harmful Effects of Metformin, An Antidiabetic Used to Treat Type 2-Diabetes: A Study on Ants as Biological Models

Cammaerts, M., & Cammaerts, D. (2022) · International Journal of Biology · doi:10.5539/ijb.v14n2p28

Metformin and kidney; overview on current concepts

Nasri, H. (2022) · Journal of Renal Endocrinology · doi:10.34172/jre.2022.21064

Glycemic and Extraglycemic Effects of Metformin in Patients with Diabetes

Rahelić, D., & Šakić, Z. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109357

Pharmacogenetics of Metformin in Type 2 Diabetes: Perspectives for Latin America

Zepeda-Carrillo, E. A., Torres‐Valadez, R., Huerta, S. A. C., & Barrón‐Cabrera, E. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108451

Changes in the Gut Microbiome as Seen in Diabetes and Obesity

Barlow, G. M., Celly, S., & Mathur, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-46712-7_5 · Cited by 1 · see citing works

The Genetic Variations Affecting the Pathophysiology and Pharmacological Treatment of Type 2 Diabetes Mellitus

Kravets, I. (2025) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921368248250305054617

Antidiabetic agents as potential cytotoxic candidates for cancer therapy

Alnaser, R. I., Alassaf, F. A., & Abed, M. N. (2024) · Forum of Clinical Oncology · doi:10.2478/fco-2023-0041

Metformina: paradigma de pleiotropismo terapéutico (1922-2025)

de Leiva, A., & Morell, F. (2025) · Medicina Clínica · doi:10.1016/j.medcli.2025.107189

Reframing metformin as a gut-targeted glucose-lowering therapy: Mechanistic insights and translational relevance

Wu, T., Horowitz, M., Jones, K. L., & Rayner, C. K. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102276

Metformin: Paradigm of therapeutic pleiotropism (1922–2025)

de Leiva, A., & Morell, F. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2025.107189

Metformin: Glycemic and Extra-Glycemic Actions

Massarini, S., & Luzi, L. (2025) · Springer eBooks · doi:10.1007/978-3-032-01700-0_10

BindingDB Entry 50008322: Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds.

BindingDB (2021) · UC San Diego · doi:10.7270/q25t3pv2

Striking a gut–liver balance for the antidiabetic effects of metformin

Barroso, E., Montori-Grau, M., Wahli, W., Palomer, X., & Vázquez‐Carrera, M. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.04.004 · Cited by 14 · see citing works

Understanding the action mechanisms of metformin in the gastrointestinal tract

Cheng, M., Ren, L., Jia, X., Wang, J., & Cong, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1347047 · Cited by 70 · see citing works

Metformin and the gastrointestinal tract

McCreight, L. J., Bailey, C. J., & Pearson, E. R. (2016) · Diabetologia · doi:10.1007/s00125-015-3844-9 · Cited by 733 · see citing works

Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids

Sansome, D. J., Xie, C., Veedfald, S., Horowitz, M., Rayner, C. K., & Wu, T. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13869 · Cited by 84 · see citing works

New Insight into the Mechanisms of the Anti-hyperglycemic Action of Metformin

Gruszka, A. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2016/23354 · Cited by 7 · see citing works